Optimization of Supplementary Nutrition Provisions of the Integrated Child Development Services of India
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2026
Project Lead
Dr Tinku Thomas
Authors
Dr Tinku Thomas, Mr. Jawahr RM, Ms. Fathima Ayoob, Mr. Ashikh Ahamad
Project Status
completed
Project Type
WHO -India